Rating History for CRISPR Therapeutics (CRSP) by UBS

More Stocks Rated by UBS | Latest Ratings for CRSP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/14/2026 N/A New Coverage Neutral
(N/A)		 52.00
(N/A)		 50.10
(50.04)		 -0.12% Details